Pauline Le Faouder Selected Research

Pauline Le Faouder Research Topics

3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 12/2018 - 08/2015
3	Inflammation (Inflammations) 12/2018 - 01/2016
2	Infections 01/2021 - 01/2015
2	Colitis 01/2021 - 08/2013
2	Hypersensitivity (Allergy) 12/2018 - 08/2015
1	Aortic Valve Stenosis (Aortic Stenosis) 04/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2019
1	Hemorrhage 04/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Hyperalgesia 12/2018
1	Abdominal Pain (Pain, Abdominal) 12/2018
1	Constipation 12/2018
1	Thrombosis (Thrombus) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Visceral Pain 11/2017
1	Neoplasms (Cancer) 01/2017
1	Pain (Aches) 08/2015
1	Melanoma (Melanoma, Malignant) 07/2015
1	Cytomegalovirus Infections (Inclusion Disease) 01/2015
1	Obesity 12/2014
1	Peritonitis 08/2013
1	Ischemia 01/2013

4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2018 - 01/2013
3	LipidsIBA 01/2018 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 04/2019 - 12/2018
2	AcidsIBA 12/2018 - 01/2015
2	SphingolipidsIBA 01/2017 - 07/2015
2	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 08/2015 - 01/2015
2	EicosanoidsIBA 08/2013 - 01/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	colibactinIBA 01/2021
1	Dextran SulfateIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2019
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2019
1	MJN110IBA 01/2019
1	5-oxo-6,8,11,14-eicosatetraenoic acidIBA 12/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2018
1	Analgesics (Analgesic Drugs)IBA 11/2017
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 11/2017
1	CeramidesIBA 01/2017
1	CaspasesIBA 01/2017
1	OxylipinsIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 08/2015
1	Transient Receptor Potential ChannelsIBA 08/2015
1	5,6-epoxy-8,11,14-eicosatrienoic acidIBA 08/2015
1	13-hydroxy-9,11-octadecadienoic acidIBA 01/2015
1	4-O-carboxymethylascochlorinIBA 01/2015
1	Biological ProductsIBA 08/2013
1	lipoxin A4IBA 01/2013
1	Hydroxyeicosatetraenoic Acids (HETE)IBA 01/2013
1	prostaglandin E3 (PGE3)IBA 01/2013
1	Leukotriene B4IBA 01/2013

2	Therapeutics 04/2019 - 11/2017
2	Injections 01/2019 - 08/2015
1	Oral Administration 01/2021
1	Transcatheter Aortic Valve Replacement 04/2019
1	Ligation 01/2019
1	Spinal Injections 08/2015
1	Hyperthermic Intraperitoneal Chemotherapy 01/2015